In this randomized controlled trial, among patients with chronic spontaneous urticaria who continue to have symptoms while on ...

This randomized controlled trial conducted in Kenya and Uganda assessed whether fractional doses of the 17D-204 yellow fever ...

Progression-free survival was significantly greater in the durvalumab plus bevacizumab group compared to placebo. 2. Common treatment-related adverse events included hypertension and anemia. Evidence ...

Older age, hypnotic drug use, and higher intraoperative fluid load were independent risk factors associated with postoperative delirium development after pancreatic surgery. Evidence Rating Level: 2 ...

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

Patients with a nonrejection-related diagnosis according to the 2019 Banff classification who were reclassified as MVI, ...

A history of endometriosis and uterine fibroids in women was associated with a greater risk of premature mortality and mortality due to gynecological cancers. 2. A history of endometriosis in women ...

People receiving acute hospital care for hallucinogen use had an increased risk of mortality compared with the general population. Evidence Rating Level: 2 (Good) The global use of hallucinogens has ...

In this randomized trial, intraosseous-first vascular access did not result in higher 30-day survival than intravenous-first ...

In this randomized controlled trial, abelacimab led to significantly lower rates of major or clinically relevant nonmajor ...

In this randomized clinical trial, among patients who had an out-of-hospital cardiac arrest, no significant difference was ...

In this randomized controlled trial, adjuvant trastuzumab emtansine (T-DM1) reduced invasive disease events in patients with ...